SIA
GILD icon

Serenity Investment Advisors’s Gilead Sciences GILD Stock Holding History

Serenity Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Sell
4,730
-30
-0.6% -$3.95K 0.29% 40
2026
Q1 		$640K Hold
4,760
– – 0.3% 41
2025
Q4 		$574K Buy
+4,760
New +$578K 0.34% 37

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Serenity Investment Advisors's GILD Position: Q2 2026 in Review

Serenity Investment Advisors reduced its Gilead Sciences (GILD) stake by 0.63% in Q2 2026, selling an estimated $3.95K and leaving 4,730 shares worth $678K. The position accounts for 0.29% of the portfolio, ranked #40.

Serenity Investment Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Serenity Investment Advisors held 4,730 shares of Gilead Sciences worth $678K as of Q2 2026.
  • Serenity Investment Advisors sold 30 Gilead Sciences shares in Q2 2026, an estimated $3.95K.
  • Gilead Sciences made up 0.29% of Serenity Investment Advisors's portfolio in Q2 2026, its #40 holding.
  • Serenity Investment Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Serenity Investment Advisors's 13F filing for Q2 2026, filed 24 Aug 2026.